-+ 0.00%
-+ 0.00%
-+ 0.00%

Galapagos Re-Evaluates Proposed Separation Amid Regulatory And Market Shifts, Explores Strategic Alternatives For Cell Therapy Business; Henry Gosebruch Named Galapagos CEO

Benzinga·05/13/2025 05:51:14
Listen to the news
  • Galapagos to re-evaluate the implementation of the previously announced separation following regulatory and market developments
  • Galapagos to explore all strategic alternatives for its existing businesses, including cell therapy, with a focus on maximizing resources available for transformative business development transactions
  • Mr. Henry Gosebruch appointed by the Galapagos Board of Directors as CEO of Galapagos, effective immediately, succeeding Dr. Paul Stoffels who announced his retirement in April 2025
  • Mr. Jérôme Contamine, formerly Lead Non-Executive Director, has been appointed Chair of the Board of Directors of Galapagos, replacing Dr. Paul Stoffels